Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-25

FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (BAJAJ MEDICAL, LLC)

View source ↗

Summary

FDA approved a supplemental application for cetirizine hydrochloride from Bajaj Medical, LLC, authorizing continued marketing of the generic antihistamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)